approval · primary record
NATALIZUMAB
FDA · BLA · 2025-03-18
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2025-03-18 |
| Brand | TYSABRI |
| Sponsor | BIOGEN IDEC |
| Route | SINGLE-USE |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:30:27.373Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:NATALIZUMAB:2025-03-18
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.